A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications
Abstract The effectiveness of nanoparticles (NP) in nanomedicine depends on their ability to extravasate from vasculature towards the target tissue. This is determined by their permeability across the endothelial barrier. Unfortunately, a quantitative study of the diffusion permeability coefficients...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e0f5d2ae4834e9e8112c4f27b90b1d4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6e0f5d2ae4834e9e8112c4f27b90b1d4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6e0f5d2ae4834e9e8112c4f27b90b1d42021-12-02T16:06:46ZA Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications10.1038/s41598-017-00750-32045-2322https://doaj.org/article/6e0f5d2ae4834e9e8112c4f27b90b1d42017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00750-3https://doaj.org/toc/2045-2322Abstract The effectiveness of nanoparticles (NP) in nanomedicine depends on their ability to extravasate from vasculature towards the target tissue. This is determined by their permeability across the endothelial barrier. Unfortunately, a quantitative study of the diffusion permeability coefficients (Pd) of NPs is difficult with in vivo models. Here, we utilize a relevant model of vascular-tissue interface with tunable endothelial permeability in vitro based on microfluidics. Human umbilical vein endothelial cells (HUVECs) grown in microfluidic devices were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of the HUVECs monolayer towards fluorescent polystyrene NPs (pNPs) of different sizes, which was determined from image analysis of their fluorescence intensity when diffusing across the monolayer. Using 70 kDa dextran as a probe, untreated HUVECs yielded a Pd that approximated tumor vasculature while HUVECs treated with 25 μg/mL cAMP had Pd that approximated healthy vasculature in vivo. As the size of pNPs increased, its Pd decreased in tumor vasculature, but remained largely unchanged in healthy vasculature, demonstrating a trend similar to tumor selectivity for smaller NPs. This microfluidic model of vascular-tissue interface can be used in any laboratory to perform quantitative assessment of the tumor selectivity of nanomedicine-based systems.Yan Teck HoGiulia AdrianiSebastian BeyerPhan-Thien NhanRoger D. KammJames Chen Yong KahNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Yan Teck Ho Giulia Adriani Sebastian Beyer Phan-Thien Nhan Roger D. Kamm James Chen Yong Kah A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
description |
Abstract The effectiveness of nanoparticles (NP) in nanomedicine depends on their ability to extravasate from vasculature towards the target tissue. This is determined by their permeability across the endothelial barrier. Unfortunately, a quantitative study of the diffusion permeability coefficients (Pd) of NPs is difficult with in vivo models. Here, we utilize a relevant model of vascular-tissue interface with tunable endothelial permeability in vitro based on microfluidics. Human umbilical vein endothelial cells (HUVECs) grown in microfluidic devices were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of the HUVECs monolayer towards fluorescent polystyrene NPs (pNPs) of different sizes, which was determined from image analysis of their fluorescence intensity when diffusing across the monolayer. Using 70 kDa dextran as a probe, untreated HUVECs yielded a Pd that approximated tumor vasculature while HUVECs treated with 25 μg/mL cAMP had Pd that approximated healthy vasculature in vivo. As the size of pNPs increased, its Pd decreased in tumor vasculature, but remained largely unchanged in healthy vasculature, demonstrating a trend similar to tumor selectivity for smaller NPs. This microfluidic model of vascular-tissue interface can be used in any laboratory to perform quantitative assessment of the tumor selectivity of nanomedicine-based systems. |
format |
article |
author |
Yan Teck Ho Giulia Adriani Sebastian Beyer Phan-Thien Nhan Roger D. Kamm James Chen Yong Kah |
author_facet |
Yan Teck Ho Giulia Adriani Sebastian Beyer Phan-Thien Nhan Roger D. Kamm James Chen Yong Kah |
author_sort |
Yan Teck Ho |
title |
A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
title_short |
A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
title_full |
A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
title_fullStr |
A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
title_full_unstemmed |
A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
title_sort |
facile method to probe the vascular permeability of nanoparticles in nanomedicine applications |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/6e0f5d2ae4834e9e8112c4f27b90b1d4 |
work_keys_str_mv |
AT yanteckho afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT giuliaadriani afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT sebastianbeyer afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT phanthiennhan afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT rogerdkamm afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT jameschenyongkah afacilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT yanteckho facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT giuliaadriani facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT sebastianbeyer facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT phanthiennhan facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT rogerdkamm facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications AT jameschenyongkah facilemethodtoprobethevascularpermeabilityofnanoparticlesinnanomedicineapplications |
_version_ |
1718384846109147136 |